Clinical trial
An exploratory phase IIa study to evaluate the safety and immunological effects of intravenous interferon?-1a (IFN?-1a, Rebif�) therapy in the induction of tolerance to IFN? in MS patients with neutralising antibodies (NAbs) to subcutaneous IFN?-1a (Rebif
Perform a �proof-of-concept� phase IIa clinical trial to induce tolerance to IFN? in subjects with NAbs to IFN?-1a.
| Category | Value |
|---|---|
| Study start date | 2010-12-08 |